Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Inmed Pharmaceuticals Inc
(NQ:
INM
)
0.3033
-0.0117 (-3.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Inmed Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
Next >
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 2023 Financial Results, Provides Business Update
May 15, 2023
Via
Investor Brand Network
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 2023 Financial Results, Provides Business Update
May 15, 2023
Via
CannabisNewsWire
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Concludes Enrollment for Phase 2 Trial Studying INM-755 Cannabinol Cream
March 28, 2023
Via
Investor Brand Network
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Peer-Reviewed Study Results Published
March 13, 2023
Via
Investor Brand Network
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
March 10, 2023
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) CEO to Present at Two March Investor Events
March 07, 2023
Via
Investor Brand Network
Life Sciences Virtual Investor Forum Agenda Announced for March 9th
March 07, 2023
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q2 2023 Financial, Corporate Report
February 21, 2023
Via
Investor Brand Network
InMed Reports Second Quarter Fiscal 2023 Financial Results and Provides Business Update
February 17, 2023
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
InMed Submits Form 12b-25
February 09, 2023
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Key Milestones, 2023 Business Outlook
January 10, 2023
Via
CannabisNewsWire
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Key Milestones, 2023 Business Outlook
January 10, 2023
Via
Investor Brand Network
InMed Provides Business Update and Milestones for 2023
January 10, 2023
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Shares Annual General Meeting Results
December 16, 2022
Via
Investor Brand Network
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Shares Annual General Meeting Results
December 16, 2022
Via
CannabisNewsWire
InMed Announces Results of 2022 Annual General Meeting
December 15, 2022
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Appoints Interim Chief Financial Officer, Changes Auditor
December 13, 2022
Via
Investor Brand Network
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
December 12, 2022
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Close on $6M Private Placement Funding
November 22, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Close on $6M Private Placement Funding
November 22, 2022
Via
CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market
November 21, 2022
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Placement Funding
November 18, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Placement Funding
November 18, 2022
Via
CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
November 18, 2022
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Accounting VP, Controller
November 17, 2022
Via
Investor Brand Network
InMed Provides Update on Management Changes
November 17, 2022
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
InMed Pharmaceuticals (NASDAQ: INM) Says Research Grant to Test Cannabinoid Analogs as a Potential Treatment for Alzheimer’s, Parkinson’s and Huntington’s Disease
November 16, 2022
InMed Pharmaceuticals, Inc. (NASDAQ: INM) is a pharmaceutical research and development company that is focused on utilizing cannabinoids and related
Via
Spotlight Growth
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Gains Alliance Grant Funding, Launches New Program with UBC Professor
November 16, 2022
Via
Investor Brand Network
InMed Pharmaceuticals Advances Neurodegenerative Disease Program with Natural Sciences and Engineering Research Council of Canada ("NSERC") Alliance Grant Funding
November 16, 2022
From
InMed Pharmaceuticals Inc.
Via
GlobeNewswire
TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2023 Financial Report, Corporate Update
November 14, 2022
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.